# Maze Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/maze-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 21 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-25T04:46:02.016886+00:00 | | Last reviewed | 2026-10-25T04:46:02.016886+00:00 | ## Identity - Legal name: Maze Therapeutics, Inc. - Display name: Maze Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-25T08:12:26.132466+00:00 | | Completeness | 0.364 | | Record Quality | 0.836 | | Directors | 9 | | Committees | 0 | | Governance events | 10 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Charles Homcy: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:6 - Daniel Spiegelman: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:7 - Jason Coloma, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:9 - Jonathan Lim: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:10 - Nancy C. Andrews: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:11 - Neil Kumar: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-01-01. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:12 - Richard Scheller: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:13 - HervĂ© Hoppenot: Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:5 - Jason Coloma: Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:8 ## Executive leadership - Charles E. Phillips: General Counsel and Corporate Secretary [GC]. Status: current. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:15 - Harold S. Bernstein, M.D., Ph.D.: President, Research and Development and Chief Medical Officer [PRESIDENT]. Status: current. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:18 - Jason Coloma, Ph.D.: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:20 - Atul Dandekar: Chief Strategy and Business Officer. Status: unknown. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:14 - Courtney Phillips: General Counsel and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:16 - Harold S. Bernstein: President, Research and Development and Chief Medical Officer [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:17 - Jason Coloma: Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:19 - Misbah Tahir: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:21 ## Governance events - GC_CHANGED: Charles E. Phillips executive of Maze Therapeutics, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-25T04:46:02.016886+00:00. event_id=alpha:event:transition:udsjmjahh8r - EXECUTIVE_APPOINTED: Harold S. Bernstein, M.D., Ph.D. executive of Maze Therapeutics, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-25T04:46:02.016886+00:00. event_id=alpha:event:transition:dtkrh1r8v2pl - CEO_CHANGED: Jason Coloma, Ph.D. executive of Maze Therapeutics, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-25T04:46:02.016886+00:00. event_id=alpha:event:transition:1jd6l3p1r218uv - DIRECTOR_APPOINTED: Neil Kumar seat on Maze Therapeutics, Inc., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-25T04:46:02.016886+00:00. event_id=alpha:event:transition:17y8y3a1ya1whc - DIRECTOR_APPOINTED: Nancy C. Andrews seat on Maze Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-25T04:46:02.016886+00:00. event_id=alpha:event:transition:158ksmc11vy2x4 - DIRECTOR_APPOINTED: Daniel Spiegelman seat on Maze Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-25T04:46:02.016886+00:00. event_id=alpha:event:transition:kedaygb02zru - DIRECTOR_APPOINTED: Jason Coloma, Ph.D. seat on Maze Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-25T04:46:02.016886+00:00. event_id=alpha:event:transition:4kt2ku19v6gia - DIRECTOR_APPOINTED: Jonathan Lim seat on Maze Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-25T04:46:02.016886+00:00. event_id=alpha:event:transition:iuzbi01x6xmw6 - DIRECTOR_APPOINTED: Richard Scheller seat on Maze Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-25T04:46:02.016886+00:00. event_id=alpha:event:transition:nm5xthz2oedt - DIRECTOR_APPOINTED: Charles Homcy seat on Maze Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-25T04:46:02.016886+00:00. event_id=alpha:event:transition:hlhb1e1eq5q1s ## Scoped resources - `alpha://company/maze-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record - `alpha://company/maze-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=identity - `alpha://company/maze-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/maze-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=board - `alpha://company/maze-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=committees - `alpha://company/maze-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=leadership - `alpha://company/maze-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=ownership - `alpha://company/maze-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=financials - `alpha://company/maze-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/maze-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=compensation - `alpha://company/maze-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=governance - `alpha://company/maze-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/maze-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=audit - `alpha://company/maze-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=legal - `alpha://company/maze-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=risk - `alpha://company/maze-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=cyber - `alpha://company/maze-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/maze-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=agents - `alpha://company/maze-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/maze-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=events - `alpha://company/maze-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=relationships - `alpha://company/maze-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=assessments - `alpha://company/maze-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - HervĂ© Hoppenot: Chairman of the Board. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. - Charles Homcy: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:6. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Daniel Spiegelman: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Jason Coloma: Chief Executive Officer and Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. - Jason Coloma, Ph.D.: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:9. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Jonathan Lim: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:10. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Nancy C. Andrews: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Neil Kumar: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:12. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Richard Scheller: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:13. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Atul Dandekar: Chief Strategy and Business Officer. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. - Charles E. Phillips: General Counsel and Corporate Secretary. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:15. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2880105a7bedf661b10c485c988d1ae4abe3b742beeb4169f8a92cade14488b5. - Courtney Phillips: General Counsel and Corporate Secretary. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. - Harold S. Bernstein: President, Research and Development and Chief Medical Officer. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. - Harold S. Bernstein, M.D., Ph.D.: President, Research and Development and Chief Medical Officer. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:18. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:76a067e50604d613b769c2e7ec1dd87c822be4c0c6fe623073200a2e562e04aa. - Jason Coloma: Chief Executive Officer. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. - Jason Coloma, Ph.D.: Chief Executive Officer and Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:20. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ea90fb70cbab8f7fddcaaf63f545131f4b8678bfc3fee014dfbd9a289a79e080. - Misbah Tahir: Chief Financial Officer. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Maze Therapeutics, Inc.. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af28e13bd27204dfd70833f3fb1119ce0622e5c2aa8dbca475ac3b0ba2b542a1. ## Entity Status - Public listing published. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af28e13bd27204dfd70833f3fb1119ce0622e5c2aa8dbca475ac3b0ba2b542a1. ## Published Fact - US. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af28e13bd27204dfd70833f3fb1119ce0622e5c2aa8dbca475ac3b0ba2b542a1. ## Security Listing - MAZE (NASDAQ). Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af28e13bd27204dfd70833f3fb1119ce0622e5c2aa8dbca475ac3b0ba2b542a1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:af28e13bd27204dfd70833f3fb1119ce0622e5c2aa8dbca475ac3b0ba2b542a1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/maze-therapeutics-inc). - alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171: [SEC DEF 14A 0001140361-26-017463](https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm). - alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456: [DEF 14A ef20071652_def14a.htm](https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm). - alpha:projection-evidence:document:2880105a7bedf661b10c485c988d1ae4abe3b742beeb4169f8a92cade14488b5: [MAZE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm). - alpha:projection-evidence:document:76a067e50604d613b769c2e7ec1dd87c822be4c0c6fe623073200a2e562e04aa: [MAZE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm). - alpha:projection-evidence:document:ea90fb70cbab8f7fddcaaf63f545131f4b8678bfc3fee014dfbd9a289a79e080: [MAZE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/maze-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/maze-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/maze-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-25T08:12:25.885026+00:00; recorded 2026-10-25T08:12:25.885026+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.